Hologic Inc. closed 22.70% short of its 52-week high of $84.67, which the company reached on August 9th.

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company ...

Leerink downgraded Hologic (HOLX) to Market Perform from Outperform with a price target of $75, down from $80, following the fiscal Q1 report.

RBC Capital analyst Conor McNamara lowered the firm’s price target on Hologic (HOLX) to $85 from $88 and keeps a Sector Perform rating on the ...

Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...

Fintel reports that on February 6, 2025, Leerink Partners downgraded their outlook for Hologic (NasdaqGS:HOLX) from Outperform to Market Perform. Analyst Price Forecast Suggests 20.21% Upside As of ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Hologic Inc. (HOLX) on Wednesday reported fiscal first-quarter profit of $201 million. On a per-share basis, the Marlborough, Massachusetts-based ...

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the ...

Learn more about whether Alcon Inc. or Hologic, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The 4th iteration of the Hologic Global Women’s Health Index reveals only 10% of survey respondents tested for any type of ...

Hologic HOLX is set to release first-quarter fiscal 2025 results on Feb. 5 after the closing bell. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus ...